Novorapid Penfill
Prescription Required
Product introduction
Novorapid Penfill is used for blood sugar control in people with type 1 and type 2 diabetes mellitus. It is a fast-acting type of insulin that helps to lower blood sugar levels after meals and reduce the chances of developing serious complications of diabetes.
Novorapid Penfill is a type of rapid-acting insulin used in the treatment of diabetes mellitus. It helps to control blood sugar level and prevents long-term complications. You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines if prescribed by your doctor. It may cause hypoglycemia (low blood sugar level) as a side effect.
Novorapid Penfill is a type of rapid-acting insulin used in the treatment of diabetes mellitus. It helps to control blood sugar level and prevents long-term complications. You should continue to exercise regularly, eat a healthy diet, and take your other diabetes medicines if prescribed by your doctor. It may cause hypoglycemia (low blood sugar level) as a side effect.
Uses of Novorapid Solution for Injection
Benefits of Novorapid Solution for Injection
In Treatment of Diabetes
Novorapid Penfill is a modern, rapid-acting form of insulin that helps to control high blood glucose (sugar) levels. It replaces the insulin that is normally produced in the body. This helps the glucose get into your cells so your body can use it for energy. It begins to lower your blood glucose level within 10-20 minutes of injecting it and the effect can last for 3-5 hours. You will need to learn exactly how, where, and when to inject this medicine for it to be most effective.
Lowering blood glucose levels helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
Lowering blood glucose levels helps reduce the risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems, and loss of limbs. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life.
Side effects of Novorapid Solution for Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Novorapid
- Hypoglycemia (low blood glucose level)
- Headache
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Upper respiratory tract infection
How to use Novorapid Solution for Injection
Your doctor or nurse will guide you how to use this medicine.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with Novorapid Penfill.
Pregnancy
SAFE IF PRESCRIBED
Novorapid Penfill is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Breast feeding
SAFE IF PRESCRIBED
Novorapid Penfill is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
Novorapid Penfill should be used with caution in patients with kidney disease. Dose adjustment of Novorapid Penfill may be needed. Please consult your doctor.
Regular monitoring of blood glucose levels is recommended for dose adjustment.
Regular monitoring of blood glucose levels is recommended for dose adjustment.
Liver
CAUTION
Novorapid Penfill should be used with caution in patients with liver disease. Dose adjustment of Novorapid Penfill may be needed. Please consult your doctor.
Frequent and regular monitoring of blood glucose levels is advised.
Frequent and regular monitoring of blood glucose levels is advised.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
No substitutes found for this medicine
Quick tips
- Novorapid Penfill helps to control blood sugar levels and avoid long-term complications.
- Take it 15 minutes before a meal or within 20 minutes after starting a meal.
- Hypoglycemia (low blood sugar level) is a common side effect. Monitor your blood sugar level regularly.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemia symptoms such as cold sweats, cool pale skin, tremors, weakness, and anxiety.
- Injection below the skin of the abdomen results in faster absorption than other injection sites.
- Injection sites must be rotated to prevent hard lumps from developing at one site.
- Opened vials/cartridges stay good at room temperature for up to 4 weeks, while unopened vials must be placed in the refrigerator (2°C–8°C).
- Do not use it if the preparation is no longer clear and colorless or if it contains particles.
Fact Box
Chemical Class
Insulin analogue
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Action Class
Insulin analogues- rapid acting
Patient concerns
User feedback
Patients taking Novorapid Penfill
Thrice A Day
46%
Once A Day
36%
Twice A Day
15%
Alternate Day
1%
Four Times A *
1%
Once A Week
1%
*Four Times A Day
What are you using Novorapid Solution for Injection for?
Type 1 diabet*
73%
Type 2 diabet*
27%
*Type 1 diabetes, Type 2 diabetes
How much was the improvement?
Excellent
39%
Average
33%
Poor
28%
What were the side-effects while using Novorapid Penfill?
Hypoglycemia *
50%
Injection sit*
25%
No Side Effec*
25%
*Hypoglycemia (low blood sugar level), Injection site allergic reaction, No Side Effect
How do you take Novorapid Solution for Injection?
With food
100%
Please rate Novorapid Penfill on price
Expensive
83%
Average
17%
FAQs
What class of medicine is Novorapid Penfill?
Novorapid Penfill belongs to the class of anti-diabetic medications. It is a type of insulin analog which is prescribed in diabetic adults and children of age 2 years and above. This medicine is used to help improve blood sugar levels and glycemic control.
What is Novorapid Penfill made from?
Novorapid Penfill is a fast-acting, man-made version of human insulin. It is produced by the process of biotechnology called recombinant DNA technology. In this technology, the DNA is purposefully altered to get the desired product by using a fungus called Saccharomyces cerevisiae. It is sold as a sterile, aqueous, clear, and colorless solution that contains insulin aspart along with other constituents like glycerin, phenol, metacresol, zinc, sodium chloride etc.
How should Novorapid Penfill be given?
The dose of Novorapid Penfill is prescribed depending upon the need of the individual. Take Novorapid Penfill regularly and take it exactly as per your doctor’s advice. It is usually given in combination with intermediate-acting or long-acting insulin. It is administered subcutaneously (under the skin) 5-10 minutes before a meal, but make sure you eat a meal or snack within 10 minutes of the insulin injection to avoid low blood sugar. It can also be given immediately after the meal.
Does Novorapid Penfill make you gain weight?
Yes, Novorapid Penfill causes weight gain when used alone or when taken along with other insulin therapies. This weight gain is a common phenomenon. The reason for weight gain is the decrease in excretion of glucose through urine. It may also occur due to the anabolic effects (promoting fat and protein formation) of insulin. Consult your doctor to know the exact reason and remedy for this.
Will I need Novorapid Penfill for the rest of my life?
f you are a type 1 diabetes patient, then yes, you have to take Novorapid Penfill for the rest of your life because your body is unable to produce sufficient insulin. Therefore, you would need Novorapid Penfill as an external source of insulin. However, if you are a type 2 diabetes patient, your doctor may ask you to stop Novorapid Penfill, in some cases, if you were able to manage your diabetes well and your blood sugar levels are controlled with exercise, diet, and oral medicines.
Can the use of Novorapid Penfill cause hypoglycemia?
Yes, the use of Novorapid Penfill can cause hypoglycemia (low blood sugar level). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. It happens more often if you miss or delay your food, drink alcohol, over-exercise, or take other antidiabetic medicines along with it. So, regular monitoring of the blood sugar level is important. Always carry some sugary candies, glucose biscuits, or fruit juice with you.
Is Novorapid Penfill fast acting?
Novorapid Penfill is a fast-acting insulin which is given to improve blood sugar levels in patients with diabetes mellitus. Since this medicine starts working very quickly as compared to the regular insulin, it controls the immediate post-meal high blood sugar. Therefore, it can be injected subcutaneously 5-10 minutes before a meal. Moreover, if you miss taking it, you can also take it after your meal.
Is Novorapid Penfill safe to be used in pregnancy?
Yes, Novorapid Penfill is considered safe to use in pregnancy if prescribed by your doctor. Your dosage may need to be adjusted by your doctor and you may also require more frequent blood glucose monitoring. Consult your doctor if you become pregnant or are planning to become pregnant while using Novorapid Penfill.
Related ayurvedic ingredients
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Powers AC, D’Alessio D. Endocrine Pancreas and Pharmacotherapy of Diabetes Mellitus and Hypoglycemia. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. p. 1251.
- Nolte MS. Pancreatic hormones and antidiabetic drugs. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 733.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 717-18.
- Insulin aspart. Bagsvaerd, Denmark: Novo Nordisk A/S; 2000 [revised Mar. 2008]. [Accessed 12 Mar. 2019] (online) Available from:
- Chaves RG, Lamounier JA. Breastfeeding and maternal medications. J Pediatr (Rio J). 2004;80(5 Suppl):S189-98. [Accessed 12 Mar. 2019] (online) Available from:
- Insulin Aspart [Product monograph]. Ontario, Canada: Novo Nordisk Canada Inc.; 2021. [Accessed 08 Oct. 2021] (online) Available from:
- Insulin Aspart [Summary of Product Characteristics]. Paris, France: Sanofi-Aventis Groupe; 2020. [Accessed 08 Oct. 2021] (online) Available from:
- Insulin aspart injection [Prescribing Information]. Bagsvaerd, Denmark: Novo Nordisk A/S; 2019. [Accessed 06 Jul. 2023]. (online) Available from:
Marketer details
Name: Novo Nordisk India Pvt Ltd
Address: Plot No.32, 47-50, EPIP Area, Whitefield, Bangalore - 560 066
Country of origin: Brazil
Lab tests offered by us
Related/Popular tests
11 people bought this recentlyDISCONTINUED
We do not facilitate sale of this product at present